World Health Organization Classification of Tumours Editorial Board (2022) Haematolymphoid Tumours, vol 11, 5th edn. International Agency for Research on Cancer, Lyon (France)

Google Scholar 

Rothenberg ME (1998) Eosinophilia. Epstein FH. ed N Engl J Med 338(22):1592–1600. https://doi.org/10.1056/NEJM199805283382206

Article  CAS  Google Scholar 

Moller D, Tan J, Gauiran DTV et al (2020) Causes of hypereosinophilia in 100 consecutive patients. Eur J Haematol 105(3):292–301. https://doi.org/10.1111/ejh.13437

Article  PubMed  CAS  Google Scholar 

Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Blood 129(6):704–714. https://doi.org/10.1182/blood-2016-10-695973

Article  PubMed  CAS  Google Scholar 

Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM (1999) The Biology of Chronic Myeloid Leukemia. Epstein FH, ed. N Engl J Med.;341(3):164–172. https://doi.org/10.1056/NEJM199907153410306

Cools J, DeAngelo DJ, Gotlib J et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214. https://doi.org/10.1056/NEJMoa025217

Article  PubMed  CAS  Google Scholar 

Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA (2023) Updates on eosinophilic disorders. Virchows Arch 482(1):85–97. https://doi.org/10.1007/s00428-022-03402-8

Article  PubMed  CAS  Google Scholar 

Shomali W, Gotlib J (2022) World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97(1):129–148. https://doi.org/10.1002/ajh.26352

Article  PubMed  CAS  Google Scholar 

WHO Classification of Tumours Editorial Board (2023) Head and Neck Tumours, vol 9, 5th edn. International Agency for Research on Cancer, Lyon (France)

Google Scholar 

Storck K, Brandstetter M, Keller U, Knopf A (2019) Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med 15(1):1. https://doi.org/10.1186/s13005-018-0186-0

Article  PubMed  PubMed Central  Google Scholar 

Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B (2010) Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer 116(16):3825–3829. https://doi.org/10.1002/cncr.25138

Article  PubMed  Google Scholar 

Cyriac S, Sagar TG, Rajendranath R, Rathnam K (2008) Hypereosinophilia in Hodgkin lymphoma. Indian J Hematol Blood Transfus 24(2):67–68. https://doi.org/10.1007/s12288-008-0031-x

Article  PubMed  PubMed Central  Google Scholar 

Vaughan Hudson B, Linch DC, Macintyre EA et al (1987) Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin’s disease (BNLI Report 31). British National Lymphoma Investigation. J Clin Pathol 40(3):247–250. https://doi.org/10.1136/jcp.40.3.247

Article  PubMed  PubMed Central  CAS  Google Scholar 

Küppers R, Hansmann ML (2005) The Hodgkin and Reed/Sternberg cell. Int J Biochem Cell Biol 37(3):511–517. https://doi.org/10.1016/j.biocel.2003.10.025

Article  PubMed  CAS  Google Scholar 

Takatsu K, Nakajima H (2008) IL-5 and eosinophilia. Curr Opin Immunol 20(3):288–294. https://doi.org/10.1016/j.coi.2008.04.001

Article  PubMed  CAS  Google Scholar 

Samoszuk M, Nansen L (1990) Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin’s disease with eosinophilia. Blood 75(1):13–16

Article  PubMed  CAS  Google Scholar 

Di Biagio E, Sánchez-Borges M, Desenne JJ, Suárez-Chacón R, Somoza R, Acquatella G (1996) Eosinophilia in Hodgkin’s Disease: a role for Interleukin 5. Int Arch Allergy Immunol 110(3):244–251. https://doi.org/10.1159/000237294

Article  PubMed  Google Scholar 

Spencer LA, Weller PF (2010) Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol 88(3):250–256. https://doi.org/10.1038/icb.2009.115

Article  PubMed  PubMed Central  Google Scholar 

Van Den Berg A, Visser L, Poppema S (1999) High expression of the CC Chemokine TARC in Reed-Sternberg cells. Am J Pathol 154(6):1685–1691. https://doi.org/10.1016/S0002-9440(10)65424-7

Article  PubMed  PubMed Central  Google Scholar 

Weihrauch MR, Manzke O, Beyer M et al (2005) Elevated serum levels of CC Thymus and activation-related chemokine (TARC) in primary Hodgkin’s Disease: potential for a prognostic factor. Cancer Res 65(13):5516–5519. https://doi.org/10.1158/0008-5472.CAN-05-0100

Article  PubMed  CAS  Google Scholar 

Kilsdonk M, Veldman C, Rosati S, Plattel W, Diepstra A (2023) The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics. Histopathology 82(3):495–503. https://doi.org/10.1111/his.14836

Article  PubMed  Google Scholar 

Conroy DM, Williams TJ (2001) Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2(3):150. https://doi.org/10.1186/rr52

Article  PubMed  PubMed Central  CAS  Google Scholar 

Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93(8):2463–2470

Article  PubMed  CAS  Google Scholar 

Jundt F, Anagnostopoulos I, Bommert K et al (1999) Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 94(6):2065–2071

Article  PubMed  CAS  Google Scholar 

Horie R, Watanabe T (1998) CD30: expression and function in health and disease. Semin Immunol 10(6):457–470. https://doi.org/10.1006/smim.1998.0156

Article  PubMed  CAS  Google Scholar 

Gruss HJ, Pinto A, Gloghini A et al (1996) CD30 ligand expression in nonmalignant and Hodgkin’s disease-involved lymphoid tissues. Am J Pathol 149(2):469–481

PubMed  PubMed Central  CAS  Google Scholar 

Horie R, Watanabe T, Morishita Y et al (2002) Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cells. Oncogene 21(16):2493–2503. https://doi.org/10.1038/sj.onc.1205337

Article  PubMed  CAS  Google Scholar 

Tóth J, Dworák O, Sugár J (1977) Eosinophil Predominance in Hodgkin’s Disease. Z Für Krebsforsch Klin Onkol 89(1):107–111. https://doi.org/10.1007/BF02571695

Article  Google Scholar 

Enblad G, Sundstrom C, Glimelius B (1993) Infiltration of eosinophils in Hodgkin’s disease involved lymph nodes predicts prognosis. Hematol Oncol 11(4):187–193. https://doi.org/10.1002/hon.2900110404

Article  PubMed  CAS  Google Scholar 

von Wasielewski R, Seth S, Franklin J et al (2000) Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors. Blood 95(4):1207–1213

Article  Google Scholar 

Axdorph U, Porwit-MacDonald A, Grimfors G, Björkholm M (2001) Tissue Eosinophilia in Relation to Immunopathological and clinical characteristics in Hodgkin’s Disease. Leuk Lymphoma 42(5):1055–1065. https://doi.org/10.3109/10428190109097726

Article  PubMed  CAS  Google Scholar 

Keresztes K, Szollosi Z, Simon Z, Tarkanyi I, Nemes Z, Illes A (2007) Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin’s lymphoma. Pathol Oncol Res 13(3):237–242. https://doi.org/10.1007/BF02893504

Article